Lewofloksacyna (Oftaquix) fluorochinolon nowej generacji w zapobieganiu zapalenia wnętrza gałki ocznej po niepowikłanych operacjach zaćmy – badanie Europejskiego Towarzystwo Chirurgów Zaćmy i Chirurgii Refrakcyjnej (European Society of Cataract and Refractive Surgeons – ESCRS)

Randomised multi-centre european clinical trial of antibiotic prophylaxis for endophthalmitis following cataract surgery – study has just begun in Poland. Poland is joining one of the largest prospective european clinical study of antibiotic prophylaxis and the largest in ophthalmology – the ESCRS endophthalmitis prophylaxis clinical trial. Up to 35 000 cataract patients are going to be recruited for this randomized, controlled, multi-centre study in 16 centres from 10 european countries. The goal is to reduce the incidence of endophthalmitis after cataract phacoemusification in Europe to less than 0.05% (less than 1 per 2 000 surgeries). The patients will be divided into four groups; different regimes of two antibiotics: cefuroxime injected intra-camerally and levofloxacine eye drops topically will be compared.